Kinetic evidence for isomerization of the dopamine receptor-raclopride complex

Neurochemistry International

Volumn 28, Issue 5-6, 1996, Pages 591-595

  Lepiku, Martin ^a,b   Rinken, Ago ^a,c   Järv, Jaak ^a   Fuxe, Kjell ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; RACLOPRIDE; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; CALCULATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; EQUILIBRIUM CONSTANT; ISOMERISM; KINETICS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALIA;

EID: 0029905350     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-0186(95)00123-9     Document Type: Article

References (20)

1. Borison R. L., Hitri A., Blowers A. J. and Diamond B. (1983) Antipsychotic drug action: clinical, biochemical and pharmacological evidence for site specificity of action. Clin. Neuropharmac. 76, 137-146.
2. Changeaux J.-P. (1990) Functional architecture and dynamics of the nicotinic acetylcholine receptors: an allosteric ligand gated ion channel. In: Fidia Research Foundation Neuroscience Award Lectures, Vol. 4, pp. 21-36. Raven Press, New York.
3. 3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex. Molec. Pharmac. 33, 402-413.
4. 3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity. J. Pharmac. exp. Ther. 250, 696-706.
5. Dohlman H. G., Thorner J., Caron M. G. and Lefkowitz R. J. (1991) Model systems for the study of seven-transmembrane-segment receptors. A. Rev. Biochem. 60, 653-688.
6. Eller M. and Järv, J. (1988) Two-step isomerization of quinuclidinyl benzilate-muscarinic receptor complex. Neurochem. Int. 12, 285-289.
7. 1 dopamine receptors in rat striatum. Eur. J. Pharmac. 121, 31-38.
8. Hulme E. C. and Birdsall N. J. M. (1992) Strategy and tactics in receptor binding studies. In: Receptor-Ligand Interactions. A Practical Approach (Hulme E. C., ed.). pp. 63-176. IRL Press, Oxford.
9. Järv J. (1992) Neurotoxic agents interacting with the muscarinic acetylcholine receptor. In: Selective Neurotoxicity (Herken H. and Hucho F., eds). pp. 659-680. Springer, Berlin.
10. Järv J. and Eller M. (1988) Kinetic aspects of L-quinuclidinyl benzilate interaction with muscarinic receptor. Neurochem. Int. 13, 419-428.
11. Järv J. and Rinken A. (1993) Muscarinic acetylcholine receptors. In: Neurotransmitter Receptors (Hucho F., ed.), pp. 199-220. Elsevier Science, Amsterdam.
12. Järv J., Hedlund B. and Bartfai T. (1979) Isomerization of the muscarinic receptor-antagonist complex. J. biol. Chem. 254, 5595-5598.
13. 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. Biochem. Pharmac. 34, 2251-2259.
14. 125I]iodosulpride, a highly selective ligand. Science 228, 752-755.
15. Peterson G. L. (1983) Determination of total protein. Meth. Enzymol. 91, 95-119.
16. Peterson G. L., Toumadje A., Johnson W. C. and Schimerlik M. I. (1995) Purification of recombinant porcine m2 muscarinic acetylcholine receptor from Chinese hamster ovary cells. Circular dichroism spectra and ligand binding properties. J. biol. Chem. 270, 17,808-17,814.
17. Schiliebs R. and Bigl V. (1984) Kinetics of the interaction of dihydroalperonal with beta-adrenergic receptors in red cerebral cortex. Gen. Physiol. Biophys. 3, 31-46.
18. Seeman P. and Van Tol H. H. M. (1994) Dopamine receptor pharmacology. Trends pharmac. Sci. 15, 264-270.
19. Strickland S., Palmer G. and Massey V. (1975) Determination of dissociation constants and specific rate constants of enzyme-substrate (or protein-ligand) interactions from rapid reaction kinetic data. J. biol. Chem. 250, 4048-4052.
20. Zoli M., Agnati L. F., Hedlund P. B., Li X. M., Ferre S. and Fuxe K. (1993) Receptor-receptor interactions an integrative mechanism in nerve cells. Molec. Neurobiol. 7, 293-334.